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The molecular distinctions between mortality stages 1 (M1; senescence) and 2 (M2; crisis) of human
replicative aging are ill defined. We demonstrate a qualitative difference between telomeric end associations at
M1 and the end fusions that produce dicentric chromosomes and breakage-fusion cycles. Knockdown of ligase
IV sufficient to completely inhibit radiation-induced dicentric chromosome formation had no effect on the
frequency of telomere associations (TAs), establishing that TAs are not covalent conventional nonhomologous
end-joining (NHEJ) products. TAs preceded and were more numerous than dicentric chromosomes. Cells
initially tolerated dicentric chromosomes without dying, but eventually, a combination of too many TAs and
dicentrics/complex chromosomal rearrangements resulted in apoptosis. We propose a working model in which
end associations represent abortive DNA repair intermediates when the number of telomeric repeats is too
small to completely inhibit DNA damage signaling but is sufficient to prevent the final covalent ligation step
of NHEJ and induces the M1 checkpoint arrest in normal human cells. Rather than being all-or-none, telomere
deprotection would thus proceed first through TAs before additional shortening leads to dicentric chromo-
somes. M2/crisis involves both qualitative changes (a shift from TAs to TAs plus dicentric chromosomes) and
quantitative changes (an increase in the number of dysfunctional telomeres).
Normal diploid human fibroblasts have a limited capacity to
divide in culture (19), which is thought to provide a barrier to the
formation of cancer. Since each mutation probably requires 20 to
40 doublings to grow to a sufficient clonal population size for the
next mutation to occur, a proliferative life span of less than 100
doublings would block precancerous cells with one or two muta-
tions from progressing to frank malignancy (52). The broad out-
line of the molecular basis for replicative aging began to emerge
when it was found that telomere length decreased with increasing
cell doublings in vitro and with donor age in vivo (9, 17, 18, 24),
suggesting that this shortening might count cell divisions. This
concept was supported by showing that that the forced expression
of the protein component of telomerase (hTERT) in human
fibroblasts was sufficient to restore telomerase activity, maintain
telomere length, and abolish the limits to cell proliferation (3, 45).
The hypothesis that the primary role of telomerase expression in
tumors was to permit escape from the replicative arrest imposed
by telomere shortening (7, 23, 26) was confirmed by inhibiting
telomerase in tumor cells and showing that this produced telo-
mere shortening and eventual proliferative failure (15, 20, 54).
We formulated a two-stage model of replicative aging (49,
53) to explain the observation that viral proteins such as the
simian virus 40 T antigen or human papillomavirus type 16
(HPV16) E6/E7 could extend the life span of human fibro-
blasts without immortalizing them. Our current interpretation
of this model (50, 51) is that mortality stage 1 (M1) occurs
when telomeres become sufficiently short to induce the cell
cycle checkpoint activities that cause senescent growth arrest.
Stasis (12), which can occur spontaneously due to inadequate
culture conditions (31) or be induced at any population dou-
bling (PD) level by overexpression of oncogenes (36, 55) or
mitomycin C (32), is a type of senescence that is not due to
short telomeres and does not represent M1. The checkpoint-
blocking activities of T antigen or E6/E7 permit additional cell
divisions beyond M1 until telomeres become so short that they
can no longer protect the ends of the chromosomes. End-to-
end fusions and chromosome breakage then result in apoptosis
and mortality stage 2 (M2; crisis). Rare cells that express fac-
tors for maintaining telomeres, either by reactivating telomer-
ase (major pathway) or a less-frequent recombination-based
ALT (alternative lengthening of telomeres) pathway (4, 5),
emerge from M2 in human fibroblasts with a frequency of
approximately 107 (39, 40).
Dysfunctional telomeres can be found in DNA damage foci
(8, 43), and specifically, the shortest telomeres are found in
such foci as cells approach senescence (56), and they contrib-
ute to genomic instability following the introduction of onco-
genes (10). Increased genomic instability has been shown to
occur in mice developing short telomeres after several gener-
ations in the absence of telomerase, and this is associated with
increased oncogenesis when combined with p53 mutations (6).
This has led to the concept that replicative aging is a two-edged
sword, in which the advantages of limiting the number of
divisions as a tumor protection strategy is finely balanced
against the genomic instability produced in checkpoint-abro-
gated cells when their telomeres get very short (1, 25).
A central unexplained facet of the two-stage model is the
mechanism by which cells deal with their short telomeres be-
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tween M1 and M2. If telomeres are sufficiently short to induce
a DNA damage response at M1, why is the apoptosis response
delayed for many doublings until M2? Is this simply a matter of
a cell being able to tolerate a few unprotected ends but de-
compensating as more ends become dysfunctional with ongo-
ing cell division? Are the short telomeres at M1 inducing
breakage-fusion cycles that produce genomic instability during
the extended life span? Alternatively, is there a difference in
the degree of deprotection that occurs as telomeres shorten so
that telomeres sufficiently short to generate a DNA damage
signal (causing them to be found in damage foci produced at
M1) are nonetheless protected from end fusion to other telo-
meres? In order to address these issues, we have monitored the
cytogenetics of cells during the extended life span produced by
the expression of HPV16 E6/E7. We observed increasing num-
bers of telomere associations (TAs; where the ends of chro-
mosomes touch without a constriction at the junction, without
any evidence of cytogenetic abnormalities) between M1 and
M2. The accumulation of these associations did not affect the
growth rate or increase apoptosis, although it was associated
with an increase in anaphase bridges. Knockdown of the non-
homologous end-joining (NHEJ) enzyme ligase IV had no
effect on the abundance of TAs, suggesting that TAs might
represent DNA repair intermediates blocked from at least the
final NHEJ step of covalent end-to-end fusions. The increase
in dicentric chromosomes (end fusion) lagged approximately
seven to eight doublings behind TAs. M2 occurred once cells
with dicentric chromosomes divided enough times to form
complex rearrangements and most cells contained both TAs
and dicentric chromosomes. We suggest that telomeres can
exist in two qualitatively different deprotected states, in which
short telomeres enter a noncovalent structure (TA) that trig-
gers a DNA damage response (M1) many doublings prior to a
change in state that produces the onset of actual end fusion
events (dicentric chromosomes) that eventually lead to cell
death (M2). This model has important implications for under-
standing normal senescence and the ongoing presence of high
levels of TAs in many cancer cells.
MATERIALS AND METHODS
Cell culture. BJ foreskin fibroblasts and derivatives of them were grown at
37°C in 5% CO2 in a 4:1 mixture of Dulbecco’s modified Eagle’s medium and
medium 199 containing 10% iron-supplemented calf serum (HyClone) and gen-
tamicin (25 g/ml; Sigma-Aldrich, St. Louis, MO). Cells were infected with a
pLXSN retrovirus expressing HPV16 E6 and E7 proteins (16) approximately 30
doublings prior to senescence and selected on G418 (400 g/ml) for 10 to 14
days. Metaphase spreads were then prepared as described below. The frequency
of anaphase bridges was determined in dividing cultures fixed three times with
methanol-acetic acid (3:1) in their original dish. The dish was then stained with
2% (vol/vol) Giemsa stain (Bio/medical Specialties, CA) in Gurr’s buffer, pH 6.8.
The frequency of apoptosis was determined by terminal deoxynucleotidyltrans-
ferase-mediated dUTP-biotin nick end-labeling analysis on cells growing on glass
coverslips using a DNA fragmentation assay kit (Clontech Laboratories, Palo
Alto, CA) according to the manufacturer’s protocol.
Metaphase spread preparation and cytogenetics analysis. Cells plated at near
confluence were incubated with colcemid (Invitrogen) the next day for 4 h. After
trypsinization, cells were treated with hypotonic KCl buffer (0.075 M) for 30 min
at 37°C and washed several times with methanol-acetic acid (3:1) until a clean,
white cell pellet was obtained. Pellets were stored at 20°C. Cells were dropped
onto slides and GTG banded using standard methods (14). Metaphase images
were captured and analyzed using Microprobe software (Apply Imaging, Inc.) at
the cytogenetics laboratory at the University of Texas Southwestern Medical
Center.
Quantitative fluorescence in situ hybridization. After being washed with phos-
phate-buffered saline (PBS) for 15 min, 1-day-old slides were fixed in formalde-
hyde (4%) in PBS for 2 min, washed with PBS three times for 5 min, and treated
with pepsin (Sigma) at 1 mg/ml at pH 2 for 10 min at 37°C. Formaldehyde
fixation and washing steps were repeated and slides were dehydrated through an
ethanol series (70%, 85%, and 100%) and air dried. The hybridization mixture
(20 l) contained 70% formamide, 15 ng 3 Cy3-conjugated (CCCTAA)3 2-
deoxyoligonucleotide N33P phosphoramidate telomeric probe (kindly pro-
vided by Sergei Gryaznov, Geron Corp.), 0.25% (wt/vol) blocking reagent
(Roche Molecular Biochemicals), and 5% MgCl2 in 10 mM Tris, pH 7.2. This
was added to the slide, denatured for 3 min at 78°C, annealed for 2 h at room
temperature, and washed twice with 70% formamide, 0.1% bovine serum albu-
min, and 10 mM Tris, pH 7.2, and twice with 0.15 M NaCl, 0.05% Tween 20, and
0.05 M Tris. The slides were then dehydrated through an ethanol series (70%,
85%, and 100%) and air dried in the dark. Chromosomes were counterstained
with Vectashield containing diamidino-phenylindole-dihydrochloride (DAPI)
(0.6 g/ml final concentration; Vector Laboratories) for chromosome identifi-
cation. Slides were digitally imaged on a Zeiss Axioplan 2 microscope (63, 1.4
numerical aperture, Plan-Apochromat oil immersion objective) with precision
Cy3/DAPI band-pass filter sets. Cy3 and DAPI images were captured separately
with a charge-coupled-device (Hamamatsu Photonics, Hamamatsu City, Japan)
camera. Quantitative fluorescence in situ hybridization analysis was performed
by ImageJ software (NIH). We used a clone of mouse NIH 3T3 cells as an
internal control to compensate for day-to-day variation due to aging of the lamp
and alignment of the optics, etc., and for conversion of the intensity measure-
ments of human telomeres to kilobases (57). Chromosomes were identified
through the banding patterns of the inverted DAPI image and karyotyped as
described above.
Immunofluorescence. Cells grown on coverslips were rinsed with PBS, fixed in
4% paraformaldehyde in PBS at room temperature (RT) for 15 min, and then
permeabilized in 0.1% Triton X-100 buffer in PBS at RT for 10 min. For dual
immunostaining, cells were first blocked with 10% bovine serum albumin (Sigma) in
PBS and then incubated at 37°C for 1 h with a mixture of primary antibodies.
Anti-phospho-histone H2AX antibody (Upstate Biologicals Inc., Lake Placid, NY)
was used at a dilution of 1:50, and anti-Mre11 antibody (12D7; GeneTex, Inc., San
Antonio, TX) was used at a dilution of 1:200. The mouse anti-53BP1 antibody was
a gift from J. Chen (Mayo Clinic and Foundation, Rochester, MN). Following
incubation, cells were washed with PBS and incubated with fluorescein isothiocya-
nate-conjugated donkey anti-rabbit and/or fluorescein isothiocyanate-conjugated
donkey anti-goat and/or tetramethyl rhodamine isothiocyanate-conjugated donkey
anti-mouse antibodies (1:200 dilution; Jackson Laboratories, Bar Harbor, ME) at
RT for 1 h. After being washed, the cells were counterstained with Vectashield
containing DAPI (Vector Laboratories) for 2 min at RT, washed with PBS, mounted
on glass slides, and imaged using a Zeiss Axioplan 2 microscope.
G1 chromosome end association analysis. Factors from mitotic cells cause
interphase chromatin to undergo a prophase-like reaction and form prematurely
condensed chromosomes (22). Premature chromosome condensation (PCC) was
performed by fusing mitotic CHO cells to interphase BJ fibroblasts and com-
bined with in situ hybridization to a whole human genome probe as described
previously (29, 37). Slides were coded and scored by researchers without knowl-
edge of the source.
Knockdown of ligase IV. BJ B14 cells (28) were infected with the pLXSN
retrovirus expressing HPV16 E6 and E7 proteins (16) and selected for G418
resistance. Both populations were then infected with a retrovirus expressing an
NHEJ reporter that contained an I-SceI restriction site, similar to the DR-green
fluorescent protein reporters previously described (30). Because it proved much
more convenient to monitor NHEJ by the response to irradiation rather than by
following the transfection with I-SceI, this reporter system was not used but
nonetheless provided duplicate populations for comparison. Aliquots of three
populations were then infected with a retrovirus with the dominant negative
hTERT D869A mutation in the reverse transcriptase motif C domain (2, 48).
Ligase IV small interfering RNA (siRNA) and control Luc siRNA were
obtained from Dharmacon RNAi Technologies (Lafayette, CO) and used at a
final concentration of 1.4 M. Ligase IV levels were determined 48 h after
transfection by Western analysis using ligase IV antibody (Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA). Cells were irradiated with 2 Gy of X rays at the
dose rate of 1 Gy/min and incubated for 12 h, and then colcemid was added and
metaphase spreads were made as described previously (38). After standard
Giemsa staining, metaphase spreads were analyzed for chromosome end asso-
ciations, which include association between chromatids of different chromo-
somes as well as sister chromatids and were different from dicentrics as shown in
Fig. 1A. Samples were coded and scored by researchers without knowledge of
prior treatments to prevent experimental bias.
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TAs during the progression between M1 and M2. End as-
sociations between chromosomes were scored as TAs if either
one or both chromatids from two chromosomes were involved,
a clear constriction indicating the junction of the two chroma-
tids was seen, and no additional chromosome anomalies were
observed. They were scored as dicentric chromosomes if both
chromatid arms from two chromosomes were involved and the
chromatids exhibited a relatively uniform diameter between
the two centromeres (Fig. 1A). Additional chromosome struc-
tural anomalies, such as deletions and/or duplications of
genomic segments, were frequently observed in dicentric chro-
mosomes. Figure 1B compares the frequencies of TAs with the
PD times and the percentages of apoptotic cells during the
period of extended life span. TAs increased during the ex-
tended life span without affecting viability or growth rate, such
that at PD 96, almost 80% of the cells had TAs without any
changes in doubling time.
TAs are not dependent on ligase IV. The presence of fre-
quent telomere end associations occurred without an increase
in apoptosis, the PD time, or an immediate appearance of
dicentric chromosomes or other chromosomal abnormalities,
such as translocations or deletions (Fig. 2). These observations
suggested that end associations might represent intermediates
in an abortive repair process rather than covalently joined
chromosomes. This could occur if a telomere still had sufficient
telomeric sequences to bind factors that partially inhibited the
DNA repair response even after it had shortened enough to
generate damage signals. Uncapped telomeres generate DNA
damage signals that are repaired by NHEJ (11, 41). In order to
examine if the TAs observed between M1 and M2 represented
noncovalent complexes, we examined the consequences of
knockdown of ligase IV, the ligase required for the final step in
NHEJ. The telomere length constantly changes between M1
and M2, and it would be technically challenging to use cells in
which the number of TAs changed with every few divisions. We
thus examined TAs in a strain of BJ fibroblasts with very short
telomeres. BJ B14 cells express extremely low levels of telo-
merase so that only the shortest telomeres can be maintained.
As a consequence, the longer telomeres shortened until they
could effectively recruit telomerase, resulting in a normal cell
with an average telomere length of only 3.5 kb, rather than
the 6 to 7 kb normally seen at senescence (28).
We introduced HPV16 E6/E7 and/or a dominant negative
telomerase with a mutation in one of the reverse transcriptase
domains (2, 48) in case these factors were needed to produce
an adequate number of TAs. In addition, we infected some
cells with what turned out to be an irrelevant reporter system
(see Materials and Methods), which provided duplicate sam-
ples and controls. All of these cells were transduced with a
ligase IV siRNA. Twenty-four hours later, aliquots of each
group were irradiated with 200 rads in order to induce chro-
mosome breaks and the formation of dicentric chromosomes,
and 1 day later, the frequencies of dicentric chromosomes and
TAs were examined. Figure 3A demonstrates a 70% de-
crease in the amount of ligase IV protein. Figure 3B shows that
this decrease was sufficient to block NHEJ, since the frequency
of dicentric chromosomes was reduced to the background level
present in the absence of irradiation. In contrast to the behav-
ior of dicentric chromosomes, the frequency of TAs remained
completely unaffected by the ligase knockdown, showing no
significant decrease in any of the seven different populations
examined (Fig. 3C). Cells were examined within approximately
six doublings of introducing the dominant-negative hTERT,
and as expected, the additional shortening occurring during
these doublings caused an increase in TAs. The increased TAs
in these cells also remained unaffected by the knockdown of
ligase IV. We conclude that ligase IV and thus covalent end
fusion by conventional NHEJ are not required for the forma-
tion of TAs. This experiment does not address whether or not
TAs represent the consequences of a blocked NHEJ complex
or other types of repair intermediates, such as homologous
recombination.
G1 TAs correlate with DNA damage foci. Telomeres short
enough to produce end associations that separated during mi-
tosis should still generate DNA damage signals and create new
end associations in G1. We thus examined the presence of end
associations in G1 and the appearance of DNA damage foci.
G1 TAs were observed by fusing interphase BJ E6/E7-ex-
pressing cells to mitotic CHO cells, thus producing prema-
turely condensed chromosomes (22, 37). The number of end
associations observed in G1 by PCC is shown in Fig. 4 and
compared to mitotic TAs Fig. 5A. Although G1 TAs were
minimal prior to M1, they increased much more rapidly than
mitotic TAs. The structure of G1 TAs is unknown, and it is
possible they do not represent the same phenomenon as meta-
phase TAs. However, if they are related, the increased num-
bers of G1 end associations in comparison to mitotic end as-
sociations implies that the sensitivity of detection by PCC is
FIG. 1. TAs between M1 and M2. (A) Examples of TAs (showing
constrictions at the junctions) and dicentrics (showing uniform chro-
matid diameters between the two centromeres). (B) The frequency of
end associations, the PD times, and apoptosis percentages are com-
pared as a function of PDs in BJ fibroblasts expressing E6/E7. The
approximate PD at which M1 would have occurred in cells lacking
E6/E7 is shown. The growth rate is the inverse of the number of days
per PD.
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greater than in metaphase spreads, that many of the G1 asso-
ciations are disrupted during replication and do not reform, or
that they are sufficiently weak that many of them are disrupted
during G2 or metaphase spread preparation (29).
The presence of DNA damage foci was analyzed by staining
cells with antibodies to a variety of factors implicated in the
repair response (Fig. 5B). -H2AX-positive DNA damage foci
increase when cells reach replicative senescence (8). Normal
diploid BJ fibroblasts (without HPV E6/E7) showed less than
0.1 focus per cell 20 doublings prior to senescence. This in-
creases to one or two foci per cell at senescence (56). At low
levels of DNA damage, the number of repair foci corresponds
to the calculated number of induced lesions (33). Figure 5C
shows the number of DNA damage foci per cell as a function
of PD and demonstrates that the number of DNA damage foci
corresponded closely to the number of TAs observed in G1.
The number occurring at the predicted M1 (PD 85 to 90; one
to two foci per cell) corresponded to what was observed in
normal BJ fibroblasts at M1 without E6/E7 (56). The appear-
ance of damage foci and specific end associations at M1 was
associated with the frequency of signal-free ends on a group of
10 chromosomes with the shortest telomeres (43, 56) and thus
very limited amounts of remaining TTAGGG repeats. Al-
though we were able detect weak telomeric repeat signals at
the junctions of 50% of the TAs by in situ hybridization, we
were unable to use immunocytochemistry to demonstrate sig-
nificant colocalization of TRF1 antibody staining with these
DNA damage foci (data not shown). Although we cannot di-
rectly demonstrate that G1 TAs are located in these DNA
damage foci, their absence prior to M1 and the quantitative
equivalence in the increases of both as a function of doublings
support this interpretation.
Dicentric chromosomes and M2. The frequency of dicentric
chromosomes between M1 and M2 is shown in Fig. 6. At PD
FIG. 2. Data for TAs and dicentric chromosomes (Dic). TAs and dicentrics were scored between PD 73 and 103. Data for specific chromatids
involved in each event are shown. The 10 shortest BJ telomeres (21p, 6p, 17q, 16q, 9q, 15p, 20p, 8q, 4q, and 5p) (56) are highlighted in gray.
Approximately 90% of all events involve at least one of these ends. Met, metaphase; SD, standard deviation; SE, standard error.
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96, 30% of the cells at metaphase contained dicentric chromo-
somes without any change in the growth rate. This suggests
that cells can survive for at least several divisions in the pres-
ence of one dicentric chromosome/cell (we never observed
more than one per cell until PD 105 [Fig. 2]) in the absence of
p53 and cell cycle checkpoints due to the presence of HPV16
E6/E7. Complex chromosome arrangements as a result of
breakage-fusion cycles first appeared at PD 101 (Fig. 2 and
6A), and their increase paralleled the increase in PD times.
These complex rearrangements thus serve as a marker for the
onset of M2.
Anaphase bridges have frequently been used as a surrogate for
end fusions and chromosome instability (27, 35). The numbers of
anaphase bridges were very high in these cells even at PD 73, well
before any TAs or dicentrics were present, presumably due to the
inhibition of checkpoint functions by HPV16 E6/E7 proteins and
DNA damage at nontelomeric sites. The frequency of anaphase
bridges rose to almost 70% by PD 87 (Fig. 6C), when TAs
were present in 34% of the cells at metaphase while dicen-
FIG. 3. TAs are not dependent on ligase IV. (A) Cells transfected
with an siRNA against ligase IV show a 70% decrease in protein
expression 48 h after transfection by Western blotting compared to
cells transfected with a control siRNA. 	, anti. (B and C) Cells trans-
fected with control or ligase IV siRNAs were exposed to 200 rads of
gamma irradiation (IR) 24 h after transfection. Metaphase spreads
were collected 24 later and analyzed for dicentric chromosomes (B) or
TAs (C). The numbers 1 and 2 (e.g., for controls 1 [Ctl 1] and 2 [Ctl
2]) represent cells infected with and without a reporter vector,
respectively, that was not used in the analysis and which thus serve
as duplicate populations. Ligase IV knockdown cells are indicated
by 2L. Two samples of nonirradiated BJ B14 E6/E7-expressing
control 2 cells were lost and thus not analyzed. A level of knock-
down sufficient to completely block dicentric chromosome forma-
tion had no effect on TAs.
FIG. 4. End associations during G1. Telomeric end associations in
G1 were determined by inducing PCC by fusing interphase BJ E6/E7-
expressing cells to mitotic CHO cells. The frequencies of telomeric end
associations in G1 are shown at different PDs. Tot, total; Av., average;
SD, standard deviation; SE, standard error.
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trics were still close to baseline. This suggests that TAs may
contribute to anaphase bridge formation.
DISCUSSION
The present results demonstrate that telomeres can exist in
at least three states with respect to end protection: (i) long
enough to be fully masked, (ii) short enough to produce dam-
age signals and noncovalent TAs, and (iii) so short that they
lose their end-protective function and cause end fusions.
Rather than being simply a quantitative change (one or a few
unprotected ends at M1 versus many at M2), the pattern of
accumulation of TAs and dicentrics suggests that both quali-
tative and quantitative changes are occurring. Using subtelo-
meric probes, we have previously shown that the shortest telo-
FIG. 5. End associations and DNA damage foci. (A) G1 TAs ap-
pear at the same time but are three to four times more numerous than
metaphase TAs. Note the change in scale from Fig. 1B. Means 

standard errors are shown. (B) Examples of DNA damage foci coex-
pressing -H2AX, NBS1, MDC1, or 53BP1. (C) The increases in DNA
damage foci monitored by -H2AX staining (average of 200 nuclei)
are quantitatively equivalent to the increases in G1 TAs. Means 

standard errors are shown.
FIG. 6. Comparison of dicentric chromosomes and TAs. (A) The
frequency of cells at metaphase containing simple dicentric chromo-
somes or those with complex rearrangements is compared to the PD
time. The appearance of complex dicentrics occurs at the same time as
M2/crisis. (B) The frequencies of TAs and dicentrics are compared.
TAs precede and are more numerous than dicentrics. Data are from
Fig. 2. Means 
 standard errors are shown. (C) The presence of
anaphase bridges is compared to that of TAs and dicentric chromo-
somes. A high baseline level of TAs is present at PD 77 prior to the
appearance of TAs or dicentrics. The dashed vertical line indicates the
PD at which anaphase bridges and TAs have increased without an
increase in dicentric chromosomes.
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meres appear in DNA damage foci as cells approach
senescence, and senescent cells contained one or two foci/cell
(56). In the present study, 40% of the cells in metaphase
contained TAs (Fig. 1B) when BJ E6/E7-expressing cells con-
tained averages of one to two DNA damage foci/cell (PD 85 to
90, when M1 occurred in control uninfected cells; Fig. 5C),
suggesting that M1 occurred when telomeres became suffi-
ciently short to induce both damage foci and TAs. As cells
progressed between M1 and M2, both TAs and dicentrics in-
creased, with the increase in TAs always preceding the increase
in dicentric chromosomes. The cells tolerated these aberra-
tions remarkably well, with no increase in growth rate or apop-
tosis until approximately PD 100, when 100% of the cells
contained TAs and 60% contained dicentrics. Beyond PD 100,
the growth rate decreased dramatically (the PD time in-
creased) and the number of chromosomes exhibiting complex
rearrangements increased in parallel. This suggests that M2 is
caused by a combination of the changes occurring after several
breakage-fusion cycles of dicentric chromosomes and having
too many end abnormalities.
The current literature on telomeres has largely discussed
end protection as an all-or-none state in which telomeres are
either properly packaged or in a form that causes them to
become fused by NHEJ to other chromosomes. The present
results demonstrate that human telomere uncapping proceeds
through at least two states, the first of which does not lead to
cytologically detectable breakage-fusion cycles for many divi-
sions. This is consistent with many other observations of the
behavior of TAs in tumor cells. Knockdown of Pot1 (21) pro-
duces an increase in TAs and telomere-induced DNA damage
foci in the absence of actual end fusions, similar to what we
have observed here. Overexpression of a TRF2 that lacks the
basic domain (44) also produces telomere dysfunction without
end fusions. The knockdown of Pot1 leads to short overhangs,
while the basic domain of TRF2 has been implicated in the
formation of t-loops (13, 42, 47). Whether either of these
manipulations models some of the events occurring between
M1 and M2 remains to be seen. If NHEJ is involved in the
formation of TAs, their ability to form in the absence of co-
valent linkage by ligase IV suggests a new regulatory influence
of telomeres on the process of NHEJ.
Anaphase bridges have been used as a surrogate marker for
end fusion events to support the contention that short telo-
meres are contributing to the ongoing genomic instability
present in tumor cells (35, 46). Anaphase bridges did increase
with the onset of end associations (Fig. 6C), suggesting that the
structures holding telomeres together in TAs resolved only late
and caused a delay in the separation of the two chromosomes.
However, anaphase bridges were also high even at PD 77,
many PDs before TAs increased at PD 87. This implies that
nontelomeric chromosome damage can also lead to anaphase
bridges in cells that lack normal DNA damage checkpoint
controls. Furthermore, anaphase bridges increased between
M1 and M2 without any significant increase in genomic insta-
bility. Anaphase bridges thus should be considered an only
moderately reliable indicator of potential telomere-driven
genomic instability in tumor cells.
Our previous understanding of the two-stage model of rep-
licative aging, the events inducing M1, and the differences
between M1 and M2 were quite vague, leading some authors to
even claim that M1 and M2 were essentially the same phenom-
enon (34). The present results demonstrate there are both
qualitative and quantitative differences between M1 and M2.
The observation that end associations separate without overt
breakage-fusion events and their formation is not dependent
on ligase IV establishes the presence of a partially capped state
distinct from fully unprotected ends, and its molecular defini-
tion will be important for models of telomere structure and
function and the changes that initiate a DNA damage signal in
comparison to those that result in end fusion. It is hoped that
our increasing understanding of the molecular details of these
processes will contribute to our ability to manipulate telomere
biology for therapeutic purposes.
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